FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2056320672> ?p ?o ?g. }

• W2056320672 endingPage "533" @default.
• W2056320672 startingPage "527" @default.
• W2056320672 abstract "IntroductionTo determine the 1-year survival, response rate, and toxicity for patients with limited stage small cell lung cancer treated with the combination of cisplatin plus etoposide plus paclitaxel with delayed concurrent (starting with cycle 3) high dose thoracic radiotherapy.Patients and MethodsPatients with previously untreated limited stage small cell lung cancer, Easter Cooperative Oncology Group performance status of 0–2 and adequate organ function were eligible. Cycles 1 and 2 of chemotherapy consisted of paclitaxel 170 mg/m2 intravenous day 1, etoposide 80 mg/m2 intravenous days 1 to 3, and cisplatin 60 mg/m2 intravenous day 1 followed by filgrastim 5 μg/kg subcutaneously days 4 to 13. Cycles 3 and 4 of chemotherapy consisted of a reduced dose of paclitaxel 135 mg/m2 intravenous day 1, and the same dose of etoposide and cisplatin with concurrent thoracic radiation therapy 1.8 Gy in 35 fractions (total 63 Gy) administered over 7 weeks.ResultsSixty-three patients were entered, 61 patients were eligible. The most common grade 4 toxicity seen was granulocytopenia (62%). Nonhematologic toxicities included febrile neutropenia in 19% of patients, grade 3 and 4 esophagitis in 32% of patients, and grade 3 peripheral neuropathy in 14% of patients. Two patients suffered lethal toxicities. The overall response rate was 79%. The 1-year survival rate was 64%. The median overall survival was 15.7 months, and the median progression-free survival was 8.6 months.ConclusionsThe combination of cisplatin plus etoposide plus paclitaxel chemotherapy and concurrent delayed thoracic radiotherapy as administered in this trial provide no apparent advantage with respect to response, local control, or survival compared with historical controls." @default.
• W2056320672 created "2016-06-24" @default.
• W2056320672 creator A5052461112 @default.
• W2056320672 creator A5057086548 @default.
• W2056320672 creator A5061771140 @default.
• W2056320672 creator A5062894702 @default.
• W2056320672 creator A5065803141 @default.
• W2056320672 creator A5078389632 @default.
• W2056320672 creator A5079283183 @default.
• W2056320672 date "2009-04-01" @default.
• W2056320672 modified "2023-10-17" @default.
• W2056320672 title "A Phase II Study of Paclitaxel + Etoposide + Cisplatin + Concurrent Radiation Therapy for Previously Untreated Limited Stage Small Cell Lung Cancer (E2596): A Trial of the Eastern Cooperative Oncology Group" @default.
• W2056320672 cites W1495781375 @default.
• W2056320672 cites W1839070320 @default.
• W2056320672 cites W1847826686 @default.
• W2056320672 cites W1884032213 @default.
• W2056320672 cites W1885320430 @default.
• W2056320672 cites W1895951835 @default.
• W2056320672 cites W1905406155 @default.
• W2056320672 cites W1923792259 @default.
• W2056320672 cites W1951799876 @default.
• W2056320672 cites W1961171505 @default.
• W2056320672 cites W1973510243 @default.
• W2056320672 cites W1973865448 @default.
• W2056320672 cites W1978074676 @default.
• W2056320672 cites W1986382059 @default.
• W2056320672 cites W1988586595 @default.
• W2056320672 cites W2008318438 @default.
• W2056320672 cites W2010947937 @default.
• W2056320672 cites W2021987821 @default.
• W2056320672 cites W2043103956 @default.
• W2056320672 cites W2049746996 @default.
• W2056320672 cites W2050188791 @default.
• W2056320672 cites W2097597328 @default.
• W2056320672 cites W2105847144 @default.
• W2056320672 cites W2110391705 @default.
• W2056320672 cites W2123767004 @default.
• W2056320672 cites W2131219536 @default.
• W2056320672 cites W2141539943 @default.
• W2056320672 cites W2150878803 @default.
• W2056320672 cites W2151177054 @default.
• W2056320672 cites W2168980896 @default.
• W2056320672 cites W2180591941 @default.
• W2056320672 cites W2180665179 @default.
• W2056320672 cites W2225293989 @default.
• W2056320672 cites W2258518953 @default.
• W2056320672 cites W2323020638 @default.
• W2056320672 cites W2339444986 @default.
• W2056320672 cites W2341745217 @default.
• W2056320672 cites W4293241248 @default.
• W2056320672 doi "https://doi.org/10.1097/jto.0b013e31819c7daf" @default.
• W2056320672 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3528175" @default.
• W2056320672 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19240650" @default.
• W2056320672 hasPublicationYear "2009" @default.
• W2056320672 type Work @default.
• W2056320672 sameAs 2056320672 @default.
• W2056320672 citedByCount "16" @default.
• W2056320672 countsByYear W20563206722012 @default.
• W2056320672 countsByYear W20563206722013 @default.
• W2056320672 countsByYear W20563206722016 @default.
• W2056320672 countsByYear W20563206722017 @default.
• W2056320672 countsByYear W20563206722018 @default.
• W2056320672 countsByYear W20563206722019 @default.
• W2056320672 countsByYear W20563206722020 @default.
• W2056320672 countsByYear W20563206722021 @default.
• W2056320672 countsByYear W20563206722022 @default.
• W2056320672 crossrefType "journal-article" @default.
• W2056320672 hasAuthorship W2056320672A5052461112 @default.
• W2056320672 hasAuthorship W2056320672A5057086548 @default.
• W2056320672 hasAuthorship W2056320672A5061771140 @default.
• W2056320672 hasAuthorship W2056320672A5062894702 @default.
• W2056320672 hasAuthorship W2056320672A5065803141 @default.
• W2056320672 hasAuthorship W2056320672A5078389632 @default.
• W2056320672 hasAuthorship W2056320672A5079283183 @default.
• W2056320672 hasBestOaLocation W20563206721 @default.
• W2056320672 hasConcept C126322002 @default.
• W2056320672 hasConcept C126894567 @default.
• W2056320672 hasConcept C141071460 @default.
• W2056320672 hasConcept C143998085 @default.
• W2056320672 hasConcept C2776256026 @default.
• W2056320672 hasConcept C2776694085 @default.
• W2056320672 hasConcept C2777063308 @default.
• W2056320672 hasConcept C2777292972 @default.
• W2056320672 hasConcept C2778119113 @default.
• W2056320672 hasConcept C2778239845 @default.
• W2056320672 hasConcept C2779134260 @default.
• W2056320672 hasConcept C2779920096 @default.
• W2056320672 hasConcept C43270747 @default.
• W2056320672 hasConcept C509974204 @default.
• W2056320672 hasConcept C71924100 @default.
• W2056320672 hasConcept C90924648 @default.
• W2056320672 hasConceptScore W2056320672C126322002 @default.
• W2056320672 hasConceptScore W2056320672C126894567 @default.
• W2056320672 hasConceptScore W2056320672C141071460 @default.
• W2056320672 hasConceptScore W2056320672C143998085 @default.
• W2056320672 hasConceptScore W2056320672C2776256026 @default.
• W2056320672 hasConceptScore W2056320672C2776694085 @default.
• W2056320672 hasConceptScore W2056320672C2777063308 @default.

• next